DaVita, Inc. (NYSE:DVA)

CAPS Rating: 3 out of 5

The Company is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease.

Recs

0
Player Avatar Rimvydas (< 20) Submitted: 10/6/2006 2:06:21 PM : Outperform Start Price: $58.53 DVA Score: +35.37

The largest kiddney dialysis network in US. Has the market locked up.

Featured Broker Partners


Advertisement